东诚药业：9月15日召开董事会会议

Company Overview - Dongcheng Pharmaceutical (SZ 002675) announced a temporary board meeting on September 15, 2025, to discuss the adjustment of the board's specialized committees and the re-election of committee members [1] - The company's revenue for the first half of 2025 was entirely derived from the biopharmaceutical industry, accounting for 100% of its revenue [1] - As of the report date, Dongcheng Pharmaceutical has a market capitalization of 13 billion yuan [1] Industry Insights - A significant breakthrough has been recognized for a new drug in China, which has been acknowledged by both Chinese and U.S. officials for its breakthrough efficacy [1] - The World Lung Cancer Conference has shown considerable excitement regarding this new drug [1]